Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    European journal of clinical pharmacology 35 (1988), S. 345-352 
    ISSN: 1432-1041
    Keywords: alpha-amylase ; cervical mucus ; ovulation ; in vitro spinability ; crystallization ; mucus rheology
    Source: Springer Online Journal Archives 1860-2000
    Topics: Chemistry and Pharmacology , Medicine
    Notes: Summary Alpha-amylase can modify ovulatory cervical mucus in vitro, changing both its structure and an essential rheological parameter, spinability. After 5 min at α-amylase concentrations above 4.6 mg/ml, spinability was greatly reduced or even non-existent because of the total liquefaction of the mucus. These concentration levels also induced breakdown of the solid phase of the hydrogel, producing more or less marked abnormalities in mucus crystallization after air drying. In the presence of the highest α-amylase concentrations (≥37.5 mg/ml) dendrites could not be formed and only sodium chloride crystals were visible at high magnification under a scanning electron microscope. In the 75 to 1.2 mg/ml concentration range, where alpha-amylase has a significant action on cervical mucus, there was an overall decrease in average spinability as the enzyme concentration fell. The action of the enzyme was greater after 10 min than after 5 min reaction time. For the 10-min reaction time interval, the activity could be adjusted using a squared polynominal regression, whereas for the 5-min reaction time interval a linear regression was a suitable model of enzymatic activity. In the 4.6 to 1.2-mg/ml concentration range, adjustment on a linear model showed that there was a significant effect of alpha-amylase concentration and reaction time on mucus spinability. Statistical analysis of the dose-effect data was compatible with the structural changes in dried cervical mucus demonstrated by scanning electron microscopy.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Amsterdam : Elsevier
    Optics Communications 106 (1994), S. 139-145 
    ISSN: 0030-4018
    Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
    Topics: Physics
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    Electronic Resource
    Electronic Resource
    Amsterdam : Elsevier
    Optics and Laser Technology 10 (1978), S. 193-196 
    ISSN: 0030-3992
    Source: Elsevier Journal Backfiles on ScienceDirect 1907 - 2002
    Topics: Electrical Engineering, Measurement and Control Technology , Physics
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 4
    ISSN: 1433-2965
    Keywords: Bone densitometry ; Calcitonin ; Gonadotropin releasing hormone agonists ; Osteopenia
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Gonadotropin releasing hormone (GnRH) agonists have shown to be effective in the treatment of several sex-hormone-dependent conditions. However, their use could be limited by the bone loss they induce. To evaluate the use of nasal salmon calcitonin (sCT) in preventing this bone loss, 40 patients with endometriosis were treated for 6 months with triptoreline (3.75 mg monthly) and calcium (1 g daily), and randomized in three groups — placebo, sCT 100 IU daily and sCT 200 IU daily — in a prospective double-masked study. Dual-energy X-ray absorptiometry and biochemical parameters were used to evaluate the benefit of the treatment. At baseline, there were no statistically significant differences between the groups. After 6 months, estradiol and biochemical markers of bone metabolism were at postmenopausal levels, with no difference between the groups. There was no difference in bone loss in the three groups, at all sites. Mean lumbar bone loss was 4.01±2.59% (mean±SD) in this population. In this study dosages of 100 IU and 200 IU daily of nasal sCT were insufficient to prevent bone loss during GnRH agonist treatment.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...